BlackRock, Inc. - 31 Dec 2024 SCHEDULE 13G/A Report for Lyell Immunopharma, Inc. Common Stock (LYEL)

Filing Manager: BlackRock, Inc.
Reporting Manager: BlackRock, Inc.
Security: Lyell Immunopharma, Inc. Common Stock
Symbol: LYEL
Shares outstanding: 294,797,089 shares
Disclosed Ownership: 13,265,869 shares
Ownership: 4.5%
Form type: SCHEDULE 13G/A
Filing time: 05 Feb 2025, 13:23:37 UTC
Date of event: 31 Dec 2024
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BlackRock, Inc.	4.5%	13,265,869	13,038,255	0	Spencer Fleming	Managing Director